CT040:免疫單藥 vs 安慰劑+化療背景:III期IMvigor130初步分析顯示,阿替利珠單抗(B組)對比安慰劑+化療(鉑類+吉西他濱)(C組)用於PD-L1表達≥5%(免疫細胞)(IC2/3,VENTANA SP142免疫組化方法)...
Read moreCT040:免疫單藥 vs 安慰劑+化療背景:III期IMvigor130初步分析顯示,阿替利珠單抗(B組)對比安慰劑+化療(鉑類+吉西他濱)(C組)用於PD-L1表達≥5%(免疫細胞)(IC2/3,VENTANA SP142免疫組化方法)...
Read more